The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C

Psoriasis treated with ustekinumab in a patient with hepatitis C

(2013) Adriana Abuchar et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient

(2012) J. Koskinas et al.   BRITISH JOURNAL OF DERMATOLOGY

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting

(2012) R. Navarro et al.   BRITISH JOURNAL OF DERMATOLOGY

T helper type 17 in psoriasis: From basic immunology to clinical practice

(2012) Hsien-Yi Chiu et al.   Dermatologica Sinica

Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept

(2012) Ting-Shun Wang et al.   Dermatologica Sinica

Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice

(2012) Fanli Meng et al.   GASTROENTEROLOGY

Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection

(2012) Chun-Ying Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management

(2012) Amanda Abramson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis

(2012) H. Q. Sun et al.   JOURNAL OF VIRAL HEPATITIS

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer

(2012) Harrys A. Torres et al.   Nature Reviews Clinical Oncology

Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy

(2011) J.-L. Lan et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials

(2011) K. Reich et al.   BRITISH JOURNAL OF DERMATOLOGY

Accelerated and Progressive and Lethal Liver Fibrosis in Mice That Lack Interleukin (IL)-10, IL-12p40, and IL-13Rα2

(2011) Margaret M. Mentink–Kane et al.   GASTROENTEROLOGY

Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan

(2011) Tsen-Fang Tsai et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: A case series in Taiwan

(2011) Yung-Tsu CHO et al.   JOURNAL OF DERMATOLOGY

Upregulation of IL-23 Expression in Patients with Chronic Hepatitis B Is Mediated by the HBx/ERK/NF- B Pathway

(2011) L. Xia et al.   JOURNAL OF IMMUNOLOGY

Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials

(2011) Kenneth B. Gordon et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The effectiveness and safety of adalimumab in the treatment of non-reimbursed patients with mild-to-moderate psoriasis

(2011) H.-Y. Chiu et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy

(2011) Roberto Pérez-Alvarez et al.   MEDICINE

Hepatocellular Carcinoma

(2011) Hashem B. El-Serag   NEW ENGLAND JOURNAL OF MEDICINE

Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review

(2011) A. M. G. Brunasso et al.   RHEUMATOLOGY

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

(2010) D. Vassilopoulos et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection

(2010) L. Nosotti et al.   BRITISH JOURNAL OF DERMATOLOGY

Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient

(2010) Pilar Martinez Montiel et al.   LIVER INTERNATIONAL

Antitumor effects and immunoregulation mechanisms of IL-23 gene in mouse mammary cancer mediated by retrovirus

(2009) Lihua Liu et al.   CELLULAR IMMUNOLOGY

Interleukin-17-producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B

(2009) Ji-Yuan Zhang et al.   HEPATOLOGY

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B

(2009) Jian Ge et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Guidelines of care for the management of psoriasis and psoriatic arthritis

(2008) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

(2008) Kim A Papp et al.   LANCET